| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Laboratory Medicine (L.S.), St. Michaels Hospital, University of Toronto, Toronto, Ontario, M5B 1W8, Canada; Genentech, Inc. (L.P.-B., W.W.), Cardiovascular Research, South San Francisco, California, and Department of Physiology (V.C., A.B.), School of Medicine, Southern Illinois University, Carbondale, Illinois 62901-6512
Address all correspondence and requests for reprints to: Lucia Stefaneanu, Ph.D., Department of Pathology, St. Michaels Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada. E-mail: L.Stefaneanu{at}utoronto.ca
Pituitary is influenced by circulating and locally produced insulin-like growth factor I (IGF-I). To further elucidate the role of pituitary IGF-I, we compared pituitary morphology of homozygous (IgfI-/-), heterozygous (IgfI+/-), and wild-type (IgfI+/+) fetal and adult mice using light microscopy, immunocytochemistry, in situ hybridization and electron microscopy. In pituitaries of Igf1-/- and Igf1+/- fetal mice (day 18.5) GH RNA signal was decreased. In Igf1-/- adult females, GH cells were significantly diminished in size; GH RNA signal was stronger in Igf1-/- mice compared with IgfI+/+ mice, and the somatotrophs had ultrastructural features of stimulation. The number of PRL cells and PRL hybridization signal were significantly decreased, however plasma PRL levels were elevated in both genders. No changes in other cell types in Igf1-/- mice, and no alterations in Igf1+/- mice were evident. IGF-I treatment for 2 weeks of Igf1-/- mice increased significantly body weights, decreased GH hybridization signal, and had no effect on PRL cells, or PRL plasma levels, whereas in IgfI+/+ mice, PRL RNA signal and PRL plasma levels were markedly increased. In conclusion, IGF-I plays no role in differentiation of pituitary cells, affects the size of somatotrophs in females, and is a stimulator of lactotrophs in both genders.
This article has been cited by other articles:
![]() |
D. L Hadsell, A. F Parlow, D. Torres, J. George, and W. Olea Enhancement of maternal lactation performance during prolonged lactation in the mouse by mouse GH and long-R3-IGF-I is linked to changes in mammary signaling and gene expression J. Endocrinol., July 1, 2008; 198(1): 61 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Senovilla, L. Nunez, C. Villalobos, and J. Garcia-Sancho Rapid Changes in Anterior Pituitary Cell Phenotypes in Male and Female Mice after Acute Cold Stress Endocrinology, May 1, 2008; 149(5): 2159 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Luque, G. Amargo, S. Ishii, C. Lobe, R. Franks, H. Kiyokawa, and R. D. Kineman Reporter Expression, Induced by a Growth Hormone Promoter-Driven Cre Recombinase (rGHp-Cre) Transgene, Questions the Developmental Relationship between Somatotropes and Lactotropes in the Adult Mouse Pituitary Gland Endocrinology, May 1, 2007; 148(5): 1946 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Hadsell, D. T. Torres, N. A. Lawrence, J. George, A. F. Parlow, A. V. Lee, and M. L. Fiorotto Overexpression of Des(1-3) Insulin-Like Growth Factor 1 in the Mammary Glands of Transgenic Mice Delays the Loss of Milk Production with Prolonged Lactation Biol Reprod, December 1, 2005; 73(6): 1116 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Rulli, A. Kuorelahti, O. Karaer, L. J. Pelliniemi, M. Poutanen, and I. Huhtaniemi Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin Endocrinology, October 1, 2002; 143(10): 4084 - 4095. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Froment, D. Seurin, S. Hembert, J. E. Levine, C. Pisselet, D. Monniaux, M. Binoux, and P. Monget Reproductive Abnormalities in Human IGF Binding Protein-1 Transgenic Female Mice Endocrinology, May 1, 2002; 143(5): 1801 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling Endocrinology, September 1, 2001; 142(9): 3764 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fruchtman, L. Jackson, and R. Borski Insulin-Like Growth Factor I Disparately Regulates Prolactin and Growth Hormone Synthesis and Secretion: Studies Using the Teleost Pituitary Model Endocrinology, August 1, 2000; 141(8): 2886 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Holzenberger, P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit Endocrinology, July 1, 2000; 141(7): 2557 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Melmed Editorial: Insulin-Like Growth Factor I--A Prototypic Peripheral-Paracrine Hormone? Endocrinology, September 1, 1999; 140(9): 3879 - 3880. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |